Criminal
Aug. 12, 2009
Off-Label Drug-Marketer Heads to Trial
The federal government is prosecuting a former pharmaceutical executive accused of fraudulently and illegally marketing a drug for an unapproved use.
Daily Journal Staff Writer Federal prosecutors are gearing up for trial in a case in which a former pharmaceutical executive is accused of fraudulently and illegally marketing a drug for an unapproved use. Off-label drug-marketing prosecutions are not uncommon against pharmaceutical companies, which usually settle the allegations with a monetary payment to the government, experts say. It is more unusual for the government to indic...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In